EUR/USD
1.16121
0.000%
Gold
4011.39
0.000%
Oil
58.457
0.000%
USD/JPY
151.594
0.000%
GBP/USD
1.33493
0.000%
GBP/JPY
202.373
0.000%
Real-time News
On October 12, the Wall Street Journal reported today (October 12), citing sources, that Hamas has informed Israel that Hamas may release the 20 surviving detainees as early as today local time.On October 12th, local time, Russian Presidential Press Secretary Dmitry Peskov stated in an interview with reporters that Russia is closely monitoring statements regarding Tomahawk cruise missiles, and the potential delivery of these weapons to Ukraine has caused serious concern in Moscow. Peskov emphasized that Tomahawk missiles are powerful weapons, but they cannot change the situation on the front lines. US Vice President Cyril Vance told the media at the end of September that the White House was considering providing Ukraine with Tomahawk cruise missiles with a range that could reach the Russian capital, Moscow, through European NATO members. On October 6th, US President Trump stated at the White House that "some decision" had been made on whether to provide Tomahawk missiles to Ukraine. On the 10th, Russian President Vladimir Putin stated that if the US provided Tomahawk missiles to Ukraine, Russia would strengthen its air defenses in response. Putin also stated that Russia has mastered a new type of weapon that will be demonstrated to the outside world in the near future, and that current testing of the weapon has been successful.On October 12th, according to the latest reports from Reuters, AFP, and other media outlets, Pakistani officials stated that Pakistan closed its border crossings with Afghanistan on the 12th following a late-night exchange of fire between the two countries armies. Reuters reported that local officials stated that the two main border crossings with Afghanistan, Tokhan and Chaman, were closed that day, along with at least three secondary crossings. As of press time, Afghanistan had not yet responded to this report.On October 12, Baili Tianheng announced that its wholly-owned subsidiary, SystImmune, has reached a milestone in its collaboration agreement with Bristol-Myers Squibb for the BL-B01D1 (EGFR×HER3 bispecific ADC) program, triggering the first $250 million in near-term contingent payments under the agreement. SystImmune will receive the payment soon, net of bank fees. Under the agreement, the company is eligible to receive up to $250 million in near-term contingent payments and up to $7.1 billion in additional payments based on the achievement of certain development, regulatory, and sales milestones.Russian Ministry of Defense: Russia shot down 72 Ukrainian drones in the past day.
